Delivery Order SPE2DB20D1100-SPE2DB25FE1EF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,587.03. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,187.40 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg, with an ultimate completion date of September 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $6,109.22. This non-set-aside, competitively awarded delivery order is classified as firm fixed price and is scheduled for completion by September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this requirement under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,245.55 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,067.34. This competitive award, effective September 19, 2025, with an ultimate completion date of September 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.47 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (quantity: 100s) on September 8, 2025, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,833.82. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) valued at $2,351.06. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a firm fixed price ceiling value of $1,891.02. The award, made on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and continues...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1EFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.57 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.999 billion and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's federal procurement activity demonstrates consistent capability to fulfill competitive pharmaceutical supply requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/25/25 |